Loading...
We zouden het geweldig vinden als je deel wordt van onze community. Word lid van onze Discord om met ons en andere leden in contact te komen!
- Ticker
- VIMIAN.ST
- Price
- 42.10
- Stock movement up
- +0.85 (2.06%)
- Company name
- Vimian Group AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Diagnostics & Research
- Marktkapitalisatie
- 21.80B
- Ent waarde
- 22.15B
- Prijs/Verkoop
- 61.86
- Prijs/Boek
- 32.62
- Div opbrengst
- -
- Div groei
- -
- Jaren van groei
- -
- FCF-uitkering
- -
- Trailing P/E
- 85148.57
- Toekomstige P/E
- 368.01
- PEG
- -
- EPS-groei
- -
- 1 jaar rendement
- 60.32%
- 3 jaar rendement
- -16.28%
- 5 jaar rendement
- -
- 10 jaar rendement
- -
Laatst bijgewerkt: 2024-12-21
DIVIDENDEN
VIMIAN.ST keert geen dividend uit
WAARDERING
Waarderingsverhoudingen
Loading...
Gegevens over waarderingsratio's
| Trailing P/E | 85148.57 |
| Prijs tot OCF | 427.87 |
| Prijs tot FCF | 610.04 |
| Prijs tot EBITDA | 431.11 |
| EV tot EBITDA | 438.04 |
Waardering (verkoop/boekwaarde)
Loading...
Waarderingsgegevens (verkoop/boekwaarde)
| Prijs tot verkoop | 61.86 |
| Prijs te boeken | 32.62 |
| EV naar verkoop | 62.85 |
FINANCIËN
Per aandeel
Loading...
Gegevens per aandeel
| Huidig aantal aandelen | 517.77M |
| WPA (TTM) | 0.00 |
| FCF per aandeel (TTM) | 0.07 |
Resultatenrekening
Loading...
Gegevens van de resultatenrekening
| Inkomsten (TTM) | 352.39M |
| Brutowinst (TTM) | 246.72M |
| Bedrijfsresultaat (TTM) | 39.38M |
| Netto inkomsten (TTM) | 256.00K |
| WPA (TTM) | 0.00 |
| Winst per aandeel (1 jaar vooruit) | 0.11 |
Marges
Loading...
Margegegevens
| Brutomarge (TTM) | 70.01% |
| Operationele marge (TTM) | 11.18% |
| Winstmarge (TTM) | 0.07% |
Balans
Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Balansgegevens
| Cash | 39.17M |
| Netto vorderingen | 53.77M |
| Totaal vlottende activa | 267.36M |
| Goodwill | 506.55M |
| Immateriële activa | 199.65M |
| Materiële vaste activa | 34.96M |
| Totaal activa | 1.06B |
| Crediteuren | 23.68M |
| Schuld op korte/lange termijn | 251.43M |
| Totaal vlottende passiva | 93.59M |
| Totaal passiva | 389.79M |
| Eigen vermogen | 668.25M |
| Netto materiële activa | 0.00 |
Kasstroom
Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Kasstroomgegevens
| Bedrijfskasstroom (TTM) | 50.95M |
| Investeringsuitgaven (TTM) | 15.21M |
| Vrije kasstroom (TTM) | 35.73M |
| Betaalde dividenden (TTM) | 0.00 |
Financieel rendement
Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Gegevens over financieel rendement
| Rendement op eigen vermogen | 0.04% |
| Rendement op activa | 0.02% |
| Rendement op geïnvesteerd kapitaal | 0.03% |
| Contant rendement op geïnvesteerd kapitaal | 3.92% |
AANDELENINFORMATIE
Voorraadgrafiek
Loading...
Koersgegevens
| Open | 41.20 |
| Dagelijks hoog | 42.60 |
| Dagelijks laag | 40.00 |
| Dagelijks volume | 1.22M |
| Hoogtepunt aller tijden | 117.16 |
| 1y analistenraming | 48.03 |
| Beta | 1.60 |
| WPA (TTM) | 0.00 |
| Dividend per aandeel | - |
| Ex-div datum | - |
| Volgende inkomsten datum | 13 Feb 2025 |
Negatief potentieel
Loading...
Nadeel potentiële gegevens
| VIMIAN.ST | S&P500 | |
| Huidige prijsdaling vanaf het hoogste punt ooit | -64.07% | -2.74% |
| Hoogste prijsdaling | -82.86% | -56.47% |
| Datum van hoogste daling | 13 Oct 2023 | 9 Mar 2009 |
| Gemiddelde daling vanaf de top | -61.84% | -11.13% |
| Gemiddelde tijd tot nieuwe high | 74 days | 12 days |
| Max tijd tot nieuwe hoogte | 866 days | 1805 days |
BEDRIJFSGEGEVENS
Marktkapitalisatie
21.80B
Marktkapitalisatie categorie
Large-cap
Beschrijving
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Werknemers
1100
Website
Investeerdersrelaties
-
SEC-dossiers
CEO
Land
Sweden
Stad
Type aandeel
-
CCC-status
-
Dividendfrequentie
-
EVENEMENTEN EN PRESENTATIES
EvenementenPresentaties
Loading...
HET BEDRIJF BEGRIJPEN
Loading...
BEDRIJFSNIEUWS
Alle nieuwsPersberichten
As global markets navigate a period of economic uncertainty marked by rate cuts from central banks and mixed performances across major indices, growth stocks continue to demonstrate resilience, with t...
18 december 2024
As global markets show resilience with U.S. indexes nearing record highs and positive sentiment buoyed by strong labor market data, investors are keenly observing potential undervalued stock opportuni...
28 november 2024
In November 2024, global markets are experiencing a notable upswing, with U.S. indices reaching record highs following the Republican "red sweep" in the elections, which has fueled optimism around pot...
13 november 2024
As European markets show resilience with the pan-European STOXX Europe 600 Index rising amid expectations of potential interest rate cuts, investors are keenly observing opportunities within individua...
14 oktober 2024
As global markets navigate through heightened geopolitical tensions and economic uncertainties, the Swedish market remains a focal point for investors seeking growth opportunities. In this environment...
9 oktober 2024
As global markets react to the recent Federal Reserve rate cut, European stocks have shown mixed performance with a cautious outlook on monetary policy. Amid this environment, identifying undervalued ...
27 september 2024
In September 2024, the Swedish market has been navigating through global economic uncertainties, with European indices experiencing notable declines amid fears of a slowdown in global growth. Despite ...
10 september 2024
As European markets continue to rally, driven by slowing inflation and optimistic economic sentiment, investors are increasingly looking toward growth opportunities in stable economies like Sweden. In...
6 september 2024
The Swedish stock market has been experiencing a period of growth, supported by positive economic indicators and subdued inflation levels. As the European Central Bank considers easing interest rates,...
6 september 2024
As European inflation nears the central bank's target, the pan-European STOXX Europe 600 Index has reached record highs, suggesting a favorable environment for value investors. In this context, identi...
5 september 2024
Volgende pagina